Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Harvard Business School
Fish and Richardson

Generated: December 15, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Abacavir Sulfate, and when can generic versions of Abacavir Sulfate launch?

Abacavir Sulfate is a drug marketed by Hetero Labs Ltd Iii, Apotex Inc, Aurobindo Pharma Ltd, Mylan Pharms Inc, Strides Pharma, Cipla Ltd, Lupin Ltd, and Teva Pharms Usa. and is included in eleven NDAs.

The generic ingredient in ABACAVIR SULFATE is abacavir sulfate; lamivudine; zidovudine. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. There are fourteen tentative approvals for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd IiiABACAVIR SULFATEabacavir sulfateSOLUTION;ORAL201107-001Sep 26, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdABACAVIR SULFATE AND LAMIVUDINEabacavir sulfate; lamivudineTABLET;ORAL206151-001Mar 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiABACAVIR SULFATEabacavir sulfateTABLET;ORAL091560-001Sep 13, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla LtdABACAVIR SULFATE AND LAMIVUDINEabacavir sulfate; lamivudineTABLET;ORAL091144-001Mar 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncABACAVIR SULFATEabacavir sulfateTABLET;ORAL201570-001Dec 17, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdABACAVIR SULFATEabacavir sulfateTABLET;ORAL077844-001Dec 17, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides PharmaABACAVIR SULFATEabacavir sulfateTABLET;ORAL091050-001Oct 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms IncABACAVIR SULFATEabacavir sulfateTABLET;ORAL091294-001Jun 18, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms UsaABACAVIR SULFATE AND LAMIVUDINEabacavir sulfate; lamivudineTABLET;ORAL079246-001Sep 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin LtdABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINEabacavir sulfate; lamivudine; zidovudineTABLET;ORAL202912-001Dec 5, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: